Ayse Uysal
Elazig, 23119, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.
Journal: Journal of clinical medicine
Published: June 30, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.
Journal: Journal of clinical medicine
Published: June 24, 2026
Evaluation of venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia: a real-life, single-center experience.
Journal: BMC cancer
Published: May 06, 2026
Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.
Journal: Journal of thrombosis and thrombolysis
Published: April 14, 2026
A survey on the management of chronic myeloid leukemia in chronic phase from the perspectives of both patients and physicians.
Journal: Annals of hematology
Published: April 12, 2026
Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.
Journal: Journal of clinical medicine
Published: February 01, 2026
The Prognostic Significance of the Systemic Inflammation Response Index (SIRI) and HALP Score in Hodgkin's Lymphoma.
Journal: Diagnostics (Basel, Switzerland)
Published: January 23, 2026
Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.
Journal: Journal of clinical medicine
Published: October 26, 2025
Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group.
Journal: Medicina (Kaunas, Lithuania)
Published: September 03, 2024
Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: October 01, 2023
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: February 26, 2023
Last Updated: 09/26/2026